Your browser doesn't support javascript.
loading
Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
Anouti, Ahmad; Patel, Madhukar S; VanWagner, Lisa B; Lee, William M; Asrani, Sumeet K; Mufti, Arjmand R; Rich, Nicole E; Vagefi, Parsia A; Shah, Jigesh A; Kerr, Thomas A; Pedersen, Mark; Hanish, Steven; Singal, Amit G; Cotter, Thomas G.
Affiliation
  • Anouti A; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Patel MS; Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
  • VanWagner LB; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Lee WM; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Asrani SK; Baylor University Medical Center, Dallas, Texas, USA.
  • Mufti AR; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Rich NE; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Vagefi PA; Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Shah JA; Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Kerr TA; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Pedersen M; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Hanish S; Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Singal AG; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Cotter TG; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Liver Transpl ; 30(1): 72-82, 2024 01 01.
Article in En | MEDLINE | ID: mdl-37490432
Recent deceased-donor allocation changes in the United States may have increased high-Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); however, outcomes in these patients remain poorly defined. We aimed to examine the impact of the MELD score on LDLT outcomes. Using UNOS data (January 1, 2010-December 31, 2021), LDLT recipients were identified and stratified into low-MELD (<15), intermediate-MELD (15-24), and high-MELD (≥25) groups. We compared outcomes between MELD-stratified LDLT groups and between MELD-stratified LDLT and donation after brain death liver transplantation recipients. We used Kaplan-Meier analysis to compare graft survival rates and multivariable Cox proportional hazards modeling to identify factors associated with graft outcomes. Of 3558 LDLTs, 1605 (45.1%) were low-MELD, 1616 (45.4%) intermediate-MELD, and 337 (9.5%) high-MELD. Over the study period, the annual number of LDLTs increased from 282 to 569, and the proportion of high-MELD LDLTs increased from 3.9% to 7.7%. Graft survival was significantly higher in low-MELD versus high-MELD LDLT recipients (adjusted HR = 1.36, 95% CI: 1.03-1.79); however, 5-year survival exceeded 70.0% in both groups. We observed no significant difference in graft survival between high-MELD LDLT and high-MELD donation after brain death liver transplantation recipients (adjusted HR: 1.25, 95% CI:0.99-1.58), with a 5-year survival of 71.5% and 77.3%, respectively. Low LDLT center volume (<3 LDLTs/year) and recipient life support requirement were both associated with inferior graft outcomes among high-MELD LDLT recipients. While higher MELD scores confer graft failure risk in LDLT, high-MELD LDLT outcomes are acceptable with similar outcomes to MELD-stratified donation after brain death liver transplantation recipients. Future practice guidance should consider the expansion of LDLT recommendations to high-MELD recipients in centers with expertise to help reduce donor shortage.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / End Stage Liver Disease Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / End Stage Liver Disease Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos